EUCTR2008-003280-40-NL进行中（未招募）不适用
Response to hepatitis A and B vaccine among children with immunesuppression due to either hiv or immunesuppressive medication - Ambirixresponse immunesuppressed children
Public Health Service Amsterdam0 个研究点开始时间: 2009年2月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All children from 1 up to and including 15 years of age, known with:
- •- hiv-infection irrespective of treatment status. The most recent tested CD4 T cell percentage should be 15% or higher (group 1); OR:
- •- juvenile idiopathic arthritis, for which one or more of the following treatments is used (orally or systemically): Prednis(ol)on = 0.25 mg/ kg body weight, or another corticosteroid in equivalent dosage; Etanercept (Enbrel®); Infliximab (Remicade®); Methotrexaat (Emthexate® or Metoject®) (group 2)
- •are eligible for inclusion.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
- •All children from 1 up to and including 15 years of age, known with:
- •- hiv-infection irrespective of treatment status. The most recent tested CD4 T cell percentage should be 15% or higher (group 1); OR:
- •- juvenile idiopathic arthritis, for which one or more of the following treatments is used (orally or systemically): Prednis(ol)on = 0.25 mg/ kg body weight, or another corticosteroid in equivalent dosage; Etanercept (Enbrel®); Infliximab (Remicade®); Methotrexaat (Emthexate® or Metoject®) (group 2)
- •are eligible for inclusion.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Not eligible for inclusion are:
- •- children who have received one or more vaccinations against hepatitis A and/ or hepatitis B before;
- •- children who have been infected with hepatitis A and/ or hepatitis B (serologically proven);
- •- children who received immunoglobulins within 6 months prior to study entrance.
- •- children known with a blood clotting disorder which prohibits intramuscular administration of the vaccine.
- •Not eligible for inclusion are:
- •- children who have received one or more vaccinations against hepatitis A and/ or hepatitis B before;
- •- children who have been infected with hepatitis A and/ or hepatitis B (serologically proven);
- •- children who received immunoglobulins within 6 months prior to study entrance.
- •- children known with a blood clotting disorder which prohibits intramuscular administration of the vaccine.
研究者
相似试验
已完成
4 期
Response to hepatitis A and B vaccine among children with immunesuppression due to either hiv or immunesuppressive medicatiojaundice1002766510047438Viral hepatitisNL-OMON38280Geneeskundige en Gezondheidsdienst (GGD) Amsterdam250
已完成
3 期
Responsiveness to the hepatitis B vaccine in Autistic childAutism.Childhood autismIRCT20130904014562N2Tehran University of Medical Sciences105
已完成
4 期
Immunological response to Hepatitis B vaccination in obsessive compulsive disorder patients receiving high doses of serotonin reuptake inhibitorsdrug-induced immunosuppression1002766510002861NL-OMON38586Academisch Medisch Centrum20
招募中
不适用
Hepatitis B vaccine efficacy in children exposed to anti-TNF in uterowerkzaamheid hepatitis B vaccinatie1001796910036411ulcerative colitisCrohn's diseaseNL-OMON40615Erasmus MC, Universitair Medisch Centrum Rotterdam24
已完成
不适用
Immune response of hepatitis B immunization in pediatric cancer survivorsThe study is an observational study and aims to evaluate the immune response to hepatitis B immunization in pediatric cancer survivors at Phramongkutklao hospitalhepatitis b virus, immune response, immunization, pediatric, cancerTCTR20201021003Phramongkutklao College of Medicine107